Methods for making and using SPR microarrays

Abstract
An article, process, and method for surface plasmon resonance plates are described. A substrate is covered with a thin metal film onto which a second thin metal film is deposited. The surface of the second thin metal film is converted to the metal oxide which is used to covalently bond organosilanes to the surface. Reactive organosilanes containing terminal bonding groups are arranged in a plurality of spots that are surrounded by inert organosilanes. Biomolecule attachment to the binding group is detected or measured from surface plasmon signals from the first thin metal film.
Description
BACKGROUND OF THE INVENTION

All patents, patent applications, and publications cited within this application are incorporated herein by reference to the same extent as if each individual patent, patent application or publication was specifically and individually incorporated by reference.


The invention relates generally to surface plasmon resonance substrates and associated methods of analyzing biomolecules. In order to analyze a DNA using surface plasmon resonance (SPR) detection, a metal such as gold having a certain thickness is required on the substrate. For application where DNA is deposited on top of gold there is the problem that gold coated glass slides have not been able to survive DNA printing processes that require corrosive oxidizers, with the gold delaminating from the surface. The gold surface must be modified by using different functionalities, the most popular being thiol chemistry. However, the Au—S bonds are vulnerable to aggressive oxidizers used for some DNA printing process. Thus, there is a need for SPR slides that are able to withstand strong oxidizers used in some DNA printing processes.


SUMMARY OF THE INVENTION

One embodiment is an article comprising: a) a substrate; b) a first metal film overlying the substrate; c) a second thin metal film, the second thin metal film having a first surface facing the first metal film, and a second surface opposed to the first surface; and d) a reactive organosilane covalently bonded to the second surface of the second thin metal film through metal-oxygen-silicon bonds. The second surface opposed to the first surface in the second thin metal film is hereafter referred to as the “upper” surface of the second thin metal film. The first metal film may be gold, silver, or copper and the second thin metal film may be Ti, Zr, Al, Cr, Hf, V, Ta, W, or Pb. Typically, the first metal film can generate surface plasmons and the upper surface of the second thin metal film is used to form chemically stable bonds to the reactive organosilane. As used herein the second thin metal film is sufficiently thin so as to allow extension of an evanescent plasmon wave from said first metal film. The resulting chips can be cleaned with aggressive oxidizers and biomolecules such as DNA, RNA, or proteins can be printed on the reactive organosilane. Chemical interactions with the printed DNA, RNA, or proteins can then be monitored through surface plasmon resonance methods. The second thin metal film may also generate surface plasmons that may interact with the surface plasmons or with surface plasmon effects from the first metal film.


Another embodiment is a process comprising: a) depositing a first metal film on a substrate; b) depositing a second thin metal film on the first metal film; c) converting the upper surface of the second thin metal film to the corresponding metal oxide; and d) reacting a functionalized organosilane with the metal oxide, whereby a reactive organosilane is formed on the upper surface of the second thin metal film. The organosilanes used typically have a reactive silane moiety and an organic substituent (i.e., trichloro-organosilanes). The terms “functionalized” and “inert” when used in connection with “organosilane” refers to the organic substituent of the silane and not the silane moiety. Another embodiment is a process comprising: a) depositing a first metal film on a substrate; b) depositing second thin metal film on the first metal film; c) converting the upper surface of the second thin metal film to the corresponding metal oxide; d) reacting an inert organosilane with the metal oxide; e) patterning the inert organosilane to give a pattern of a plurality of metal oxide spots surrounded by inert organosilane; and f) reacting a functionalized organosilane with the metal oxide, whereby a reactive organosilane is formed in the metal oxide spots on the second thin metal film. Another embodiment is a process comprising: a) depositing a first metal film on a substrate; b) depositing a second thin metal film on the first metal film; c) converting the upper surface of the second thin metal film to the corresponding metal oxide; d) applying a patterned photoresist on the upper surface defining a plurality of spots, the upper surface being exposed between spots; e) reacting an inert organosilane on the metal oxide of the upper surface; f) removing the photoresist to form a plurality of metal oxide spots; and g) reacting a functionalized organosilane with the metal oxide, whereby a reactive organosilane is formed in the metal oxide spots. A similar embodiment is a process comprising: a) depositing a first metal film on a substrate; b) depositing second thin metal film on the first metal film; c) patterning a photoresist on the upper surface into a plurality of spots, the surface of the second thin metal film being exposed between spots; d) converting the surface of the second thin metal film between spots to a metal oxide; e) reacting an inert organosilane with the metal oxide of the second thin metal film; f) removing the photoresist to form a plurality of spots comprising the surface of the second thin metal film; g) converting the surface of the second thin metal film in the spots into a metal oxide, whereby a plurality of metal oxide spots is formed; and h) reacting a functionalized organosilane with the metal oxide spots, whereby a reactive organosilane is formed in the metal oxide spots on the second thin metal film.


Another embodiment is a method, comprising a) providing an article including: i) a substrate; ii) a first metal film overlying the substrate; iii) a second thin metal film overlying the first metal film; iv) an organosilane covalently bonded to the exposed upper surface of the second thin metal film through metal-oxygen-silicon bonds; v) a binding group attached to the organosilane; b) contacting the article with a biomolecule; and c) determining whether or not the biomolecule is bound to the binding group by detecting or measuring a surface plasmon resonance signal generated from the first metal film.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a cross-sectional view of a process scheme.



FIG. 2 is a cross-sectional view of a process scheme.



FIG. 3 is a cross sectional view of a process scheme.



FIG. 4 is a cross-sectional view of a process scheme.





DETAILED DESCRIPTION

One embodiment is an article comprising: a) a substrate; b) a first metal film overlying the substrate; c) a second thin metal film overlying the first metal film; and d) a reactive organosilane covalently bonded to the upper surface of the second thin metal film through metal-oxygen-silicon bonds. The first metal film may be gold, silver, or copper and the second thin metal film may be Ti, Zr, Al, Cr, Hf, V, Ta, W, or Pb. Typically, the first metal film can generate surface plasmons and the upper surface of the second metal film is used to form chemically stable bonds to the reactive organosilane. When the second thin metal film is sufficiently thin, the evanescent wave of the surface plasmons generated by the first metal film extend through the second thin metal film and can be used to detect chemical changes near the upper surface of the second thin metal film. Detecting these chemical changes can be used, for example, to monitor biological molecule binding and image dielectric thin films. Typically, the substrate is glass or quartz. In other embodiments, the substrate comprises one face of a prism. The article may further comprise an adhesion metal layer between the substrate and the first metal film. The adhesion metal layer typically is Cr, Ti, W, or any combination thereof.


In many embodiments, the reactive organosilane has a pattern on the surface that is a plurality of spots. In most embodiments, the spots are arranged in a microarray. Hydrophobic material may surround one or more of the reactive organosilane spots. The hydrophobic material may cause a polar liquid (e.g., water) to bead on the reactive organosilane spot, which allows the spot to be used as a microwell. The size of each spot is typically 10-1000 μm in diameter, and the density of spots is typically 100 to 1 million spots per square centimeter. The hydrophobic material typically comprises an inert organosilane covalently bonded to the upper surface of the second thin metal film through metal-oxygen-silicon bonds. The inert organosilane may include, for example, a fluorinated alkyl group. In many embodiments, the reactive organosilane comprises hydroxy groups. The hydroxy groups may be capped with DNA or RNA (e.g., DNA or RNA have been reacted with the hydroxyl groups to form covalent bonds). An example of a reactive organosilane comprises the structure




embedded image



wherein: R is a reactive group and n=1-20. The reactive group R may comprise, for example, the structures




embedded image



wherein m=1-10. One example of an inert organosilane comprises the structure




embedded image



wherein: q=1-4; and p=1-20. In some embodiments, the reactive organosilane comprises the structure




embedded image



and the hydrophobic material comprises the structure




embedded image



wherein: R is a reactive group; X is independently at each occurrence a hydrogen or halogen; n=1-20; and q=1-20. The reactive group R may be as described above. The distance between the upper surface of the second thin metal film and the reactive group R on the reactive organosilane, and the distance between the upper surface of the second thin metal film and the non-bonded terminus of the hydrophobic material are controlled through the appropriate selection of alkyl (—(CH2)n—), or haloalkyl (—(CX2)q—, where X is a halogen) chain lengths.


Another embodiment is a process comprising: a) depositing a first metal film on a substrate; b) depositing a second thin metal film on the first metal film; c) converting the upper surface of the second thin metal film to the corresponding metal oxide; and d) reacting a functionalized organosilane with the metal oxide, whereby a reactive organosilane is formed on the upper surface of the second thin metal film. The first metal film, the second thin metal film, and the substrate may be as described above. In many embodiments, converting the upper surface of the second thin metal film to the corresponding metal oxide comprises oxygen plasma treatment. In one embodiment, the functionalized organosilane is




embedded image



wherein: R3 is chlorine or alkoxy; p=1-20; and the reactive organosilane comprises




embedded image



In other embodiments, the reactive organosilane is




embedded image



and the process further comprises converting the reactive organosilane to




embedded image



In some embodiments, the process further comprises patterning the reactive organosilane into a plurality of spots. In one embodiment, the process further comprises reacting the reactive organosilane with DNA or RNA.


Another embodiment is a process comprising: a) depositing a first metal film on a substrate; b) depositing a second thin metal film on the first metal film; c) converting the upper surface of the second thin metal film to the corresponding metal oxide; d) reacting an inert organosilane on the upper surface of the second thin metal film; e) patterning the inert organosilane to give a pattern of a plurality of metal oxide spots surrounded by inert organosilane; and f) reacting a functionalized organosilane with the metal oxide, whereby a reactive organosilane is formed in the metal oxide spots on the second thin metal film. Another embodiment is a process comprising: a) depositing a first metal film on a substrate; b) depositing a second thin metal film on the first metal film; c) converting the upper surface of the second thin metal film to the corresponding metal oxide; d) patterning a photoresist on the upper surface into a plurality of spots, the upper surface being exposed between spots; e) reacting an inert organosilane on the metal oxide of the upper surface; f) removing the photoresist to form a plurality of metal oxide spots; and g) reacting a functionalized organosilane with the metal oxide, whereby a reactive organosilane is formed in the metal oxide spots. A similar embodiment is a process comprising: a) depositing a first metal film on a substrate; b) depositing second thin metal film on the first metal film; c) patterning a photoresist on the upper surface into a plurality of spots, the surface of the second thin metal film being exposed between spots; d) converting the surface of the second thin metal film between spots to a metal oxide; e) reacting an inert organosilane with the metal oxide of the second thin metal film; f) removing the photoresist to form a plurality of spots comprising the surface of the second thin metal film; g) converting the surface of the second thin metal film in the spots into a metal oxide, whereby a plurality of metal oxide spots is formed; and h) reacting a functionalized organosilane with the metal oxide spots, whereby a reactive organosilane is formed in the metal oxide spots on the second thin metal film. The substrate, the first metal film, and the second thin metal film may be as described above. The inert organosilane typically includes a fluorinated alkyl group, for example the structure




embedded image



wherein: q=1-4; and p=1-20. The functionalized organosilane and the reactive organosilane may be as described above. In one embodiment, the reactive organosilane is




embedded image



and the process further comprises converting the reactive organosilane to




embedded image



The size of each spot is typically 10-1000 μm in diameter, and the number the density of spots is typically 100 to 1 million spots per square centimeter. The distance between the upper surface of the second thin metal film and the reactive group R on the reactive organosilane, and the distance between the upper surface of the second thin metal film and the non-bonded terminus of the hydrophobic material are controlled through the appropriate selection of alkyl (—(CH2)n—), or haloalkyl (—(CX2)q—, where X is a halogen) chain lengths.


Another embodiment is a method, comprising a) providing an article including: i) a substrate; ii) a first metal film overlying the substrate; iii) a second thin metal film overlying the first metal film; iv) an organosilane covalently bonded to the upper surface of the second thin metal film through metal-oxygen-silicon bonds; and v) a binding group attached to the organosilane; and b) determining whether or not the biomolecule is bound to the binding group by detecting or measuring a surface plasmon resonance signal generated from the first metal film. In some embodiments, the binding group comprises DNA or RNA. The biomolecule is typically DNA, RNA, or a protein. In other embodiments, the binding group is an antigen, an antibody, or a hapten. The organosilane may have a pattern of a plurality of spots. The spots may be arranged in a microarray. The size of each spot is typically 10-1000 μm in diameter, and the number the density of spots is typically 100 to 1 million spots per square centimeter. The first metal film, the second thin metal film, and the glass substrate may be as described above.


EXAMPLES

The following example(s) is illustrative and does not limit the Claims.


A glass substrate was cleaned using Diamaflow 688C. The substrate was soaked in a 1% solution of Diamaflow 688C in DI-water (18MΩ) with and sonicated for 5 minutes. After sonication, the samples were brushed in a fresh solution of Diamaflow and DI-water and sonicated again in DI-water at 30° C. in 15 minutes. The substrate was rinsed for 5 minutes and dried with filtered N2 gas. Before the metal deposition the substrate was treated with high pressure O2 plasma for 5 minutes. The plasma cleaning process should happen right before the metal deposition otherwise the surface conditions cannot be precisely controlled. The metal deposition was performed in a Denton Discovery 18 DC magnetron sputtering machine. The base pressure was less than 2×10−7 Torr. Argon was used as process gas at a pressure of 7.5 mTorr during deposition. The magnetron current was set to 250 mA. First, a 2 nm thick adhesion layer of Cr was deposited followed by deposition of a 47 nm Au layer, followed by deposition of a 10 nm thick layer of Ti.


Deposition of the inert hydrophobic organosilane and reactive organosilane are shown schematically in cross section in FIGS. 1-2. After metal deposition the substrate was photolithographically patterned with photoresist (1) squares (100-200 μm on one side). Following development, an O2-plasma treatment was used to enhance the bonding of the hydrophobic silane to the Ti. A solution of 1H, 1H, 2H, 2H perfluoroundecyl trichlorosilane was spin deposited, rinsed with toluene, and dried with N2 gas. The remaining photoresist was removed using a stripper, washed with an isopropyl alcohol and DI-water rinse, and dried with filtered N2 gas. At this point the Ti surface (2) was exposed as a series of spots surrounded by the hydrophobic silane (3). The exposed Ti surface was treated with O2 plasma. (Glycidoxypropoxy)trimethoxysilane was spin deposited as described above for the hydrophobic silane to give the reactive organosilane (4) patterned into series of spots, with each spot surrounded by the hydrophobic organosilane (3). The epoxy-reactive silane was converted to a hydroxy-reactive silane by treatment with H2O/HCl (FIG. 3) or ethylene glycol (FIG. 4).

Claims
  • 1. A method of determining binding between a binding group and a biomolecule comprising: a) providing an article including: i) a substrate;ii) a first metal film overlying the substrate;iii) a second thin metal selected from the group consisting of Ti, Zr, Al, Cr, Hf, V, Ta, W and Pb, wherein the thin metal film includes a proximal surface and a distal surface, wherein the proximal surface is proximal to the first metal film and the distal surface is distal to the first metal film; andiv) the binding group attached to the distal surface of the second thin metal film;b) contacting the article with the biomolecule; andc) measuring a surface plasmon resonance signal to determine the binding between the binding group and the biomolecule.
  • 2. The method of claim 1, wherein the binding group is selected from the group consisting of DNA and RNA.
  • 3. The method of claim 2, wherein the biomolecule is selected from the group consisting of DNA, RNA, and a protein.
  • 4. The method of claim 1, wherein the binding group is selected from the group consisting of an antigen, an antibody, and a hapten.
  • 5. The method of claim 1, wherein the first metal film is selected from the group consisting of Au, Ag, and Cu.
  • 6. The method of claim 1, wherein the substrate is made from a material selected from the group consisting of glass and quartz.
  • 7. An article for determining binding between a binding group and a biomolecule comprising: i) a substrate;ii) a first metal film overlying the substrate;iii) a second thin metal film selected from the group consisting of Ti, Zr, Al, Cr, Hf, V, Ta, W and Pb, wherein the second thin metal film includes a proximal surface and a distal surface, wherein the proximal surface is proximal to the first metal film and the distal surface is distal to the first metal film; andiv) the binding group attached to the distal surface of the second thin metal film, wherein contacting the article with the biomolecule and measuring a surface plasmon resonance signal determines binding between the binding group and the biomolecule.
  • 8. The article of claim 7, wherein the first metal film is selected from the group consisting of Au, Ag, and Cu.
  • 9. The article of claim 7, wherein the substrate is made from a material selected from the group consisting of glass and quartz.
  • 10. The article of claim 7, wherein the binding group is selected from the group consisting of DNA and RNA.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a divisional of copending U.S. patent application Ser. No. 11/296,659, filed on Dec. 6, 2005; which application is incorporated herein by reference in its entirety.

US Referenced Citations (201)
Number Name Date Kind
3105902 Ostrofsky Oct 1963 A
3751587 Insler Aug 1973 A
3891507 Breuer Jun 1975 A
3990850 Friedman Nov 1976 A
4038030 Albright Jul 1977 A
4148057 Jesse Apr 1979 A
4375025 Carlson Feb 1983 A
4585931 Duncan Apr 1986 A
4638144 Latta Jan 1987 A
4707722 Folk Nov 1987 A
4719502 Ikeya Jan 1988 A
4753863 Spanjer Jun 1988 A
4789804 Karube Dec 1988 A
4861620 Azuma Aug 1989 A
4945045 Forrest Jul 1990 A
4945204 Nakamura Jul 1990 A
4997278 Finlan Mar 1991 A
5030551 Herren Jul 1991 A
5068124 Batey Nov 1991 A
5078855 Mochizuki Jan 1992 A
5089112 Skotheim Feb 1992 A
5104619 de Castro Apr 1992 A
5116481 Ozawa May 1992 A
5157412 Kleinschmick Oct 1992 A
5192507 Taylor Mar 1993 A
5200051 Cozzette Apr 1993 A
5206280 Williams Apr 1993 A
5242828 Bergstrom Sep 1993 A
5246846 Pittner Sep 1993 A
5262470 Shimotsuma Nov 1993 A
5268305 Ribi Dec 1993 A
5313264 Ivarsson May 1994 A
5329090 Woelki Jul 1994 A
5346802 Ohbachi Sep 1994 A
5357077 Tsuruta Oct 1994 A
5368712 Tomich Nov 1994 A
5373039 Sakai Dec 1994 A
5401378 King Mar 1995 A
5405783 Pirrung Apr 1995 A
5413629 Yasui May 1995 A
5415838 Rieger May 1995 A
5436161 Bergstrom Jul 1995 A
5436170 Cornell Jul 1995 A
5445923 Takahashi Aug 1995 A
5445934 Fodor et al. Aug 1995 A
5474796 Brennan Dec 1995 A
5478756 Gizeli Dec 1995 A
5485277 Foster Jan 1996 A
5491097 Ribi Feb 1996 A
5492840 Malmqvist Feb 1996 A
5512131 Kumar Apr 1996 A
5514501 Tarlov May 1996 A
5527711 Tom-Moy Jun 1996 A
5536822 Haystead Jul 1996 A
5567301 Stetter Oct 1996 A
5571568 Ribi Nov 1996 A
5580794 Allen Dec 1996 A
5622872 Ribi Apr 1997 A
5624537 Turner Apr 1997 A
5629790 Neukermans May 1997 A
5637201 Raguse Jun 1997 A
5688642 Chrisey Nov 1997 A
5693477 Cornell Dec 1997 A
5707502 McCaffrey Jan 1998 A
5716778 Weng Feb 1998 A
5719060 Hutchens Feb 1998 A
5723345 Yamauchi Mar 1998 A
5736410 Zarling Apr 1998 A
5741409 Raguse Apr 1998 A
5753093 Raguse May 1998 A
5756355 Lang May 1998 A
5783054 Raguse Jul 1998 A
5798030 Raguse Aug 1998 A
5824483 Housten Oct 1998 A
5834224 Ruger Nov 1998 A
5844099 Stahl Dec 1998 A
5846842 Herron Dec 1998 A
5922594 Lof Jul 1999 A
5922617 Wang Jul 1999 A
5938595 Glass Aug 1999 A
5942388 Willner Aug 1999 A
5955379 Lennox Sep 1999 A
5985377 Corbet Nov 1999 A
6020208 Hutchens Feb 2000 A
6027942 Hutchens Feb 2000 A
6040193 Winkler et al. Mar 2000 A
6054270 Southern Apr 2000 A
6074616 Beuchler Jun 2000 A
6096825 Garnier Aug 2000 A
6101946 Martinsky Aug 2000 A
6113992 Corbet Sep 2000 A
6146593 Pinkel Nov 2000 A
6150147 Goldberg et al. Nov 2000 A
6165335 Lennox et al. Dec 2000 A
6197599 Chin Mar 2001 B1
6217949 Corbet Apr 2001 B1
6218111 Southern et al. Apr 2001 B1
6218194 Lyndin Apr 2001 B1
6219138 Swanson Apr 2001 B1
6225047 Hutchens May 2001 B1
6225625 Pirrung et al. May 2001 B1
6232066 Felder May 2001 B1
6245590 Wine Jun 2001 B1
6261776 Pirrung et al. Jul 2001 B1
6291155 Raguse Sep 2001 B1
6291183 Pirrung et al. Sep 2001 B1
6309831 Goldberg et al. Oct 2001 B1
6322970 Little Nov 2001 B1
6329209 Wagner Dec 2001 B1
6340597 Svorc Jan 2002 B1
6346413 Fodor et al. Feb 2002 B1
6362912 Lewis Mar 2002 B1
6379929 Burns Apr 2002 B1
6380365 Akerstrom Apr 2002 B1
6399365 Besemer et al. Jun 2002 B2
6406921 Wagner Jun 2002 B1
6416952 Pirrung et al. Jul 2002 B1
6421164 Tearney Jul 2002 B2
6433907 Lippert Aug 2002 B1
6447723 Schermer Sep 2002 B1
6448065 Laugharn Sep 2002 B2
6448089 Vuong Sep 2002 B1
6461490 Lennox et al. Oct 2002 B1
6472179 Stahl Oct 2002 B2
6478939 Lennox et al. Nov 2002 B1
6482593 Walt Nov 2002 B2
6485918 Schermer Nov 2002 B1
6489106 Shivashankar Dec 2002 B1
6491871 Fodor et al. Dec 2002 B1
6545758 Sandstrom Apr 2003 B1
6548171 Barbera-Guillem Apr 2003 B1
6558623 Ganz May 2003 B1
6565813 Garyantes May 2003 B1
6569385 Little May 2003 B1
6576424 Fodor et al. Jun 2003 B2
6576426 Southern et al. Jun 2003 B2
6586193 Yguerabide Jul 2003 B2
6600031 Fodor et al. Jul 2003 B1
6610482 Fodor et al. Aug 2003 B1
6733977 Besemer et al. May 2004 B2
6785433 Tiefenthaler Aug 2004 B2
6787368 Wong Sep 2004 B1
6789040 Kaushikkar Sep 2004 B2
6800453 Labaer et al. Oct 2004 B2
6806361 Kajisa et al. Oct 2004 B1
6862094 Johansen Mar 2005 B2
6870627 Elkind Mar 2005 B2
6902705 Caillat Jun 2005 B1
6911344 Reichert Jun 2005 B1
6980294 Namba Dec 2005 B2
6999175 Ivarsson Feb 2006 B2
7041208 Staats May 2006 B2
7081954 Sandstrom Jul 2006 B2
7084980 Jones et al. Aug 2006 B2
7126688 Rassman Oct 2006 B2
7251085 Bahatt et al. Jul 2007 B2
7312069 Ban Dec 2007 B2
7319046 Misiakos Jan 2008 B2
7463358 Wolf et al. Dec 2008 B2
20020024495 Lippert Feb 2002 A1
20020044893 Corn Apr 2002 A1
20020068813 Dragic Jun 2002 A1
20020127565 Cunningham Sep 2002 A1
20020140938 Naya Oct 2002 A1
20020197729 Tsuzuki Dec 2002 A1
20030082820 Perbost May 2003 A1
20030100004 Kurz May 2003 A1
20030107741 Pyo Jun 2003 A1
20030143576 Chao et al. Jul 2003 A1
20040008345 Nurmikko Jan 2004 A1
20040014946 Chao Jan 2004 A1
20040043384 Oleinikov Mar 2004 A1
20040048311 Ault-Riche Mar 2004 A1
20040067597 Datwani Apr 2004 A1
20040161748 He et al. Aug 2004 A1
20040174518 Naiki Sep 2004 A1
20040198637 Schultz et al. Oct 2004 A1
20040214233 Lubman Oct 2004 A1
20040248144 Mir Dec 2004 A1
20040258832 Barklund et al. Dec 2004 A1
20050002085 Matsui Jan 2005 A1
20050014179 Karlsson et al. Jan 2005 A1
20050046848 Cromwell Mar 2005 A1
20050095577 Yang May 2005 A1
20050200845 Nabatova-Gabain et al. Sep 2005 A1
20060091051 Takada May 2006 A1
20060134669 Casasanta Jun 2006 A1
20060154320 Zuk Jul 2006 A1
20060187459 Ok Aug 2006 A1
20060234265 Richey et al. Oct 2006 A1
20070009198 Petcavich Jan 2007 A1
20070059817 Aoyagi Mar 2007 A1
20070081163 Liang et al. Apr 2007 A1
20070099180 Robotti et al. May 2007 A1
20070122314 Strand May 2007 A1
20070128455 Wolf Jun 2007 A1
20070139653 Guan et al. Jun 2007 A1
20070140918 Yin Jun 2007 A1
20070222996 Guan et al. Sep 2007 A1
20090060786 Kim et al. Mar 2009 A1
20090060787 Kim et al. Mar 2009 A1
Foreign Referenced Citations (10)
Number Date Country
10064146 Dec 2000 DE
WO 9315110 Aug 1993 WO
WO 9531480 Nov 1995 WO
WO 9602830 Feb 1996 WO
WO 9609547 Mar 1996 WO
WO 9707593 Jan 1997 WO
WO 9741424 Jan 1997 WO
WO 9741425 Jan 1997 WO
WO 9712988 Apr 1997 WO
WO 02052260 Jul 2002 WO
Related Publications (1)
Number Date Country
20090093067 A1 Apr 2009 US
Divisions (1)
Number Date Country
Parent 11296659 Dec 2005 US
Child 12330384 US